tissue-type plasminogen activator - Globe Thesis

Keyword [tissue-type plasminogen activator] Result: 101 - 118 \| Page: 6 of 6
101.	Clinical Analysis Of Intravenous Thrombolysis With Rt-PA 3 To 4.5 Hours After Acute Ischemic Stroke
102.	A Preliminary Study Of Branch Atheromatous Disease In The Territory Of Anterior Choroidal Artery And On Efficacy And Safety Of Intravenous Thrombolysis In Patients With Branch Atheromatous Disease
103.	844 A/G Polymorphism Of PAI-1 Gene In Association With Fibrinolytic Bleeding After Cardiac Surgery Employing CPB
104.	Effect Of Intravenous Thrombolysis With Recombinant Tissue Type Plasminogen Activator For Patients With Acute Mild Ischemic Stroke
105.	The Clinical Observation Of External Ventricular Drainage Plus Recombinant Tissue-type Plasminogen Activator For Hematoma Evacuation In Patients With Intraventricular Hemorrhage
106.	Analysis Of The Efficacy,Prognosis And Safety Of Rt-PA Intravenous Thrombolytic Therapy In Patients With Both Acute Ischemic Stroke And Atrial Fibrillation
107.	Detection And Analysis Of Hyper Coagulable State In Patients With Chronic Heart Failure
108.	TM/TAT/PIC/t-PAIC Diagnosis Of Disseminated Intravascular Coagulation Prospective Clinical Study
109.	Study On The Diagnosis And Treatment Of Sudden Death Caused By Acute Pulmonary Embolism
110.	Risk Factors Of Hemorrhagic Transformation After Intravenous Thrombolysis With Rt-PA In Patients With Acute Cerebral Infarction
111.	A new role for tissue-type plasminogen activator in liver injury
112.	Characterization of the interactions between neuroserpin and tissue-type plasminogen activator
113.	Factors affecting glycosylation site occupancy of Asn-184 of tissue-type plasminogen activator produced in Chinese hamster ovary cells
114.	Mechanism Of Acupuncture Regulating RhoA/ROCK Signaling Pathway To Improve The Safety Of Thrombolysis In Cerebral Infarction And Clinical Effect Observation
115.	Effects Of Exendin-4 Via GSK-3?/?-catenin Signaling Pathway On Reducing The Damage Of Hemorrhagic Transformation Induced By RtPA After Ischemic Stroke
116.	Effects Of Intraventricular Recombinant Tissue Type Plasminogen Activator On DCI And Prognosis After Aneurysmal Subarachnoid Hemorrhage
117.	Therapeutic Effect Of Recombinant Tissue-type Plasminogen Activator Thrombolysis On Early Mild Stroke
118.	Effects Of Clozapine On Plasma No,vWF,tPA And PAI-1 In Sprague-daley Rats
<<First <Prev Next> Last>> Jump to